Enlace a algunos de los artículos ya publicados para este mes de Mayo. Estenosis del stent, antiagregantes nuevos para la patología isquémica miocárdica: Prasugrel; uso del factor VIIa, Clostridium Difficile, descontaminación selectiva, PCO2 destete de la ventilación mecánica, y un suplemento especial del Clinical Infectious Disease sobre las infecciones urinarias por Cándida. Estos son los artículos a los que se puede acceder.

Restenosis: Delineating the Numerous Causes of Drug-Eluting Stent  Restenosis.

Vasim Farooq, Bill D. Gogas, and Patrick W. Serruys

Circ Cardiovasc Interv 2011;4 195-205.

CO2 Response and  Duration of Weaning From Mechanical Ventilation.

Raurich JM, Rialp G, Ibáñez J, Llompart-Pou JA, Ayestarán I.

Respir Care. 2011 Apr 15.

Systematic Review: Benefits and Harms of In-Hospital Use of Recombinant Factor VIIa for Off-Label Indications.

Yank V, Tuohy CV, Logan AC, Bravata DM, Staudenmayer K, Eisenhut R, Sundaram V, McMahon D, Olkin I, McDonald KM, Owens DK, Stafford RS.

Ann Intern Med. 2011 Apr 19;154(8):529-40.

High Doses of Clopidogrel to Overcome Genetic Resistance The Randomized Crossover CLOVIS-2 (Clopidogrel and Response Variability Investigation Study 2).

Collet JP, Hulot JS, Anzaha G, Pena A, Chastre T, Caron C, Silvain J, Cayla G, Bellemain-Appaix A, Vignalou JB, Galier S, Barthélémy O, Beygui F, Gallois V, Montalescot G; CLOVIS-2 Investigators.

JACC Cardiovasc Interv. 2011 Apr;4(4):392-402.

Prasugrel Overcomes High On-Clopidogrel Platelet Reactivity Post-Stenting More Effectively Than High-Dose (150-mg) Clopidogrel The Importance of CYP2C19*2 Genotyping.

Alexopoulos D, Dimitropoulos G, Davlouros P, Xanthopoulou I, Kassimis G, Stavrou EF, Hahalis G, Athanassiadou A.

JACC Cardiovasc Interv. 2011 Apr;4(4):403-410.

Epidemiology and control of Clostridium difficile infections in healthcare settings: an update.

Barbut F, Jones G, Eckert C.

Curr Opin Infect Dis. 2011 Apr 19.

Selective digestive tract decontamination and selective oropharyngeal decontamination and antibiotic resistance in patients in intensive-care units: an open-label, clustered group-randomised, crossover study   

Anne Marie GA de Smet, Jan AJW Kluytmans, Hetty EM Blok, Ellen M Mascini, Robin FJ Benus, Alexandra T Bernards, Ed J Kuijper, Maurine A Leverstein-van Hall, Arjan R Jansz, Bartelt M de Jongh, Gerard J van Asselt, Ine HME Frenay, Steven FT Thijsen, Simon NM Conijn, Jan A Kaan, Jan P Arends, Patrick DJ Sturm, Martin CJ Bootsma, Marc JM Bonten

Lancet Infectious disease. 2011 May; (11) 5: 372-380.

CandidaUrinary Tract Infections

Candida Urinary Tract Infections—Epidemiology, Pathogenesis, Diagnosis, and Treatment: Executive Summary.

John F. Fisher

Clin Infect Dis. (2011) 52(suppl 6): S429-S432

Candida Urinary Tract Infections—Epidemiology

Jack D. Sobel, John F. Fisher, Carol A. Kauffman, and Cheryl A. Newman

Clin Infect Dis. (2011) 52(suppl 6): S433-S436

Candida Urinary Tract Infection: Pathogenesis

John F. Fisher, Kevin Kavanagh, Jack D. Sobel, Carol A. Kauffman, and Cheryl A. Newman

Clin Infect Dis. (2011) 52(suppl 6): S437-S451

Candida Urinary Tract Infections—Diagnosis

Carol A. Kauffman, John F. Fisher, Jack D. Sobel, and Cheryl A. Newman

Clin Infect Dis. (2011) 52(suppl 6): S452-S456

Candida Urinary Tract Infections—Treatment

John F. Fisher, Jack D. Sobel, Carol A. Kauffman, and Cheryl A. Newman

Clin Infect Dis. (2011) 52(suppl 6): S457-S466